Emisphere Technologies
Cedar Knolls, NJ, Company and Business Contact Information
Emisphere Technologies Company Information
| Emisphere Technologies, Inc. | |
| 240 Cedar Knolls Rd Ste 200 Cedar Knolls, NJ, 07927-1621 www.emisphere.com |
|
| USA | |
| +1.973.532.8000 | |
| Healthcare, Pharmaceuticals, & Biotech | |
| 111 | |
| $8.40M | |
| Publicly Traded - NASDAQ : EMIS |
| Sales | 26 |
| Marketing | 8 |
| Finance & Admin | 27 |
| Human Resources | 1 |
| Support | 2 |
| Engineering & Research | 19 |
| Operations | 3 |
| IT & IS | 5 |
| C-Level | 10 |
| VP-Level | 8 |
| Director-Level | 16 |
| Manager-Level | 18 |
| Staff | 26 |
What is Jigsaw?
- Find who's who in the company and get their contact information
- Provides company information for Emisphere Technologies, Inc. along with millions of other companies
- Get business contacts in every industry as Healthcare, Pharmaceuticals, & Biotech at your fingertips
- Find accurate data for companies as Emisphere Technologies, Inc. in Cedar Knolls
- All business contacts are complete with full name, title, postal address, hard-to-find email address and telephone number in every state as NJ
- Find out who is connected to whom at Emisphere Technologies, Inc. as well as other companies in the Healthcare, Pharmaceuticals, & Biotech industry
emisphere.com - Jigsaw Company Wiki Page
Emisphere was founded in 1986 as Clinical Technologies Associates, Inc. In the early 1990's, the company narrowed its strategic focus to the development of its oral drug delivery technology and, in 1992, officially became Emisphere Technologies, Inc. Emisphere is currently a development stage company. The company's revenues are predominately derived from payments made by pharmaceutical and biotech companies for early development work performed by Emisphere on their behalf, or for the achievement of agreed upon milestones. Should any partnered program generate a successful product, Emisphere will receive additional royalty payments ...Jigsaw - Your Information Source on Companies & Business Contacts.